Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma: Results of the Compassionate Use or the Expanded Access Program in Spain

  1. de la Rubia, J.
  2. Alonso, R.
  3. Clavero, M.E.
  4. Askari, E.
  5. García, A.
  6. Antón, C.
  7. Fernández, M.
  8. Escalante, F.
  9. García, A.
  10. Rios-Tamayo, R.
  11. Conesa, V.
  12. Bermúdez, M.A.
  13. Merchán, B.
  14. Velasco, A.E.
  15. Blanchard, M.J.
  16. Sampol, A.
  17. Gainza, E.
  18. Hernández, P.M.
  19. Alegre, A.
Aldizkaria:
Cancers

ISSN: 2072-6694

Argitalpen urtea: 2023

Alea: 15

Zenbakia: 11

Mota: Artikulua

DOI: 10.3390/CANCERS15112964 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus